Dr. Pruthvi Raj Velamala, MD

Dr. Velamala practices at Beverly Hospital in Beverly, Massachusetts, part of Beth Israel Lahey Health.

Dr. Velamala's NPI, 1114411154, was assigned on June 21, 2018. Dr. Velamala holds Massachusetts license 1018531.

Dr. Velamala's primary practice is Beverly Hospital, at 85 Herrick Street, Beverly, MA 01915 in Essex County. The practice phone is (978) 922-3000.

Dr. Velamala's primary practice is Beverly Hospital in Beverly, Massachusetts, part of Beth Israel Lahey Health. Dr. Velamala is also affiliated with Lahey Clinic. The medical group on file is Beth Israel Lahey Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Velamala practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Velamala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Velamala is licensed in Massachusetts.

CMS data shows 92 Medicare services from Dr. Velamala across 2 procedure codes in 2024, for 116 Medicare patients. Medicare paid $11,518 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Velamala in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Velamala's median patient age at 69, with 64% women.

In 2024, Dr. Velamala wrote 15 Medicare Part D claims. Every claim was for a generic drug. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $103 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Velamala for performance year 2024, reported through an alternative payment model (APM). Dr. Velamala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Velamala as offering telehealth.

Dmand AI links 1 paper to Dr. Velamala in 2019. Dr. Velamala's most frequent co-author is Amos Lal, MD.

CMS Open Payments shows 42 general payments to Dr. Velamala from 18 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $230.